The US Army Medical Research and Development Command (USAMRDC) and Empatica have partnered to help deploy a wearable solution for early detection of Covid-19.

The multi-phased project will involve the use of Empatica’s Aura algorithm and medical smartwatch, EmbracePlus.

The initiative is expected to support efforts to safeguard the general population and mitigate the outbreak of the infection in the early and pre-symptomatic stages via early detection and alerting.

The Aura algorithm is designed to interpret and assess the user’s health and risk of infection daily. It is based on the physiological data collected by EmbracePlus.

An alert is set off to the individual if the algorithm detects early and potential signs of infection.

The project will commence with the algorithm’s clinical validation on healthy participants. The complete platform will be tested and validated in a virtual clinical study.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Submissions to the US Food and Drug Administration (FDA) for regulatory approvals will also be conducted at the same time.

EmbracePlus’s clinical-grade sensors will measure heart rate, heart rate variability, temperature, respiratory rate, and electrodermal activity.

Empatica CEO Matteo Lai said: “It is a privilege for our team to participate in the effort to combat Covid-19 together with the USAMRDC.

“The department arguably has the world’s best track record in sponsoring and fostering ground-breaking technologies.

“Their inspiration to intervene and act with this initiative brings into sharp focus the impact Covid-19 has had in our daily lives, as well as the need to work together to face the challenge.

“This is not only a technological race against time, but also a civic responsibility in employing our experience against a threat to our health and economy.”